Chinese AI biotech company MegaRobo raises nearly $200 million
Original headline中国 AI 生物技术公司 MegaRobo 融资近 2 亿美元
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
China’s AI biotechnology company MegaRobo Technologies has raised nearly $200 million in a funding round that included Oman’s sovereign wealth fund, the Oman Investment Authority. CMBI and existing investors Asia Investment Capital, Granite Asia and Sinovation Ventures also participated, according to a company statement cited by Bloomberg. MegaRobo said the proceeds will go toward research and development and global expansion. The deal highlights continued investor appetite for AI-enabled biotech platforms in China despite a broader funding slowdown. Next, watch how MegaRobo deploys the capital to scale internationally and whether the round draws further sovereign and crossover investment into the sector.
Muhabbit's AI wrote this summary in its own words from TechFlow's report and translated it from Chinese. It can get details wrong, so check the source.
Named in this story
MegaRobo Technologies, Oman Investment Authority, CMBC International, Asia Investment Capital, Sinovation Ventures, Granite Asia